Company / Current Assets per Share
UroGen Pharma Ltd. Current Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$4.40
FY2025
5-year range
$4.40 / $8.50
FY2021-FY2025
Trend
-48.2%
vs FY2024
Sector context
#141 of 210
Health Care
What the data says
At $4.40, UroGen Pharma Ltd.'s current assets per share ranks #141 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 9 years, ranging from $4.40 in FY2025 to $9.17 in FY2019.
Based on SEC 10-K filings.
4.40 in FY2025 with a 5-year CAGR of -4.3%.
Declined from $7.31 to $4.40 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -8.4%
- 5-Year CAGR
- -4.3%
- 10-Year CAGR
- -
Sector benchmark
#141 of 210 in Health CareTop 67% of 210This company $4.40 Sector average $170.65
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 48.2% year-over-year.
- Ranks #141 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.40 | -48.2% |
| FY2024 | $8.50 | +16.2% |
| FY2023 | $7.31 | +27.5% |
| FY2022 | $5.74 | +11.2% |
| FY2021 | $5.16 | -6.2% |
| FY2020 | $5.50 | -40.0% |
| FY2019 | $9.17 | +23.3% |
| FY2018 | $7.44 | -3.0% |
| FY2017 | $7.66 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026